Kolexia
Vallard Alexis
Oncologie radiothérapie
Chu De Martinique Site De Clarac
Fort-de-France, France
186 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du col de l'utérus Tumeurs du sein Carcinomes Tumeurs de la prostate Récidive tumorale locale Carcinome épidermoïde Tumeurs du rectum Tumeurs de la tête et du cou Tumeurs du poumon

Industries

Janssen
9 collaboration(s)
Dernière en 2023
IQVIA
6 collaboration(s)
Dernière en 2022
Ipsen
5 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2023

Dernières activités

GETUG-StORM-01: A Randomized Phase II Study Assessing Stereotactic Radiotherapy in Therapeutic Strategy of Oligoprogressive Renal Cell Carcinoma Metastases
Essai Clinique (Centre François-Baclesse)   31 juillet 2023
Type II endometrial cancer: Incidence, overall and disease-free survival in Martinique.
PloS one   16 mars 2023
PRESTO: Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients - a GETUG-AFU Phase III Randomized Controlled Trial
Essai Clinique (Unicancer)   15 février 2023
Recove® burn ointment for managing acute radiodermatitis in patients with breast cancer: A double blind randomized controlled trial.
Caspian journal of internal medicine   05 août 2022
Providing Patients with Locally Advanced Cervical Cancer Access to Brachytherapy: Experience from a Referral Network for Women Treated in Overseas France.
Cancers   14 juin 2022
Preservation of organs related to future sexual function during prostate stereotactic body radiotherapy: feasibility analysis through a re-optimization process.
Medical dosimetry : official journal of the American Association of Medical Dosimetrists   10 juin 2022
Dose to pelvic lymph nodes in locally advanced cervical cancer during high-dose-rate brachytherapy with tandem-ring applicators.
Journal of contemporary brachytherapy   06 avril 2022
RPAH2: Moderate Hypofractionated Radiotherapy (62 Gy in 20 Fractions of 3.1 Gy) Versus Stereotactic Radiotherapy (37.5 Gy in 5 Fractions of 7.5 Gy) With Hyaluronic Acid Injection Between the Prostate and the Rectum for Prostate Cancer of Low- to Intermediate Risk; RPAH2
Essai Clinique (Hospices Civils de Lyon)   02 mars 2022
Local treatment in the setting of de novo metastatic rectal cancer: reappraisal of prognostic factors.
Swiss medical weekly   15 décembre 2021
Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol.
Head & neck   13 octobre 2021